Abstract
The effects of diclofenac, a nonsteroidal antiinflammatory drug, on the biliary and urinary excretion of ceftriaxone were evaluated in subjects with a T drain in the common bile duct. The kinetic study was carried out on the sixth postoperative day of treatment with ceftriaxone alone (2 g intravenously; group 1) or ceftriaxone combined with diclofenac (50 mg every 12 h orally from postoperative days 3 to 6; group 2). A significant increase in the elimination half-life of ceftriaxone was observed in group 2 patients. Diclofenac caused a significant rise in ceftriaxone biliary excretion. This increase was not sufficient to balance the significant deficit of urinary excretion of ceftriaxone.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANTON A. H. A drug-induced change in the distribution and renal excretion of sulfonamides. J Pharmacol Exp Ther. 1961 Dec;134:291–303. [PubMed] [Google Scholar]
- Carbon C., Contrepois A., Nivoche Y., Grandjean M., Decourt S., Chau N. P. Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits. J Pharmacol Exp Ther. 1981 Aug;218(2):537–543. [PubMed] [Google Scholar]
- Carbon C., Dromer F., Brion N., Cremieux A. C., Contrepois A. Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits. Antimicrob Agents Chemother. 1984 Sep;26(3):373–377. doi: 10.1128/aac.26.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davies B. I., Maesen F. P. Drug interactions with quinolones. Rev Infect Dis. 1989 Jul-Aug;11 (Suppl 5):S1083–S1090. doi: 10.1093/clinids/11.supplement_5.s1083. [DOI] [PubMed] [Google Scholar]
- Dekel S., Francis M. J. The treatment of osteomyelitis of the tibia with sodium salicylate. An experimental study in rabbits. J Bone Joint Surg Br. 1981 Aug;63-B(2):178–184. doi: 10.1302/0301-620X.63B2.7217138. [DOI] [PubMed] [Google Scholar]
- Hayton W. L., Schandlik R., Stoeckel K. Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy. Eur J Clin Pharmacol. 1986;30(4):445–451. doi: 10.1007/BF00607958. [DOI] [PubMed] [Google Scholar]
- Joly V., Pangon B., Brion N., Vallois J. M., Carbon C. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac. J Pharmacol Exp Ther. 1988 Aug;246(2):695–700. [PubMed] [Google Scholar]
- Kampmann J., Hansen J. M., Siersboek-Nielsen K., Laursen H. Effect of some drugs on penicillin half-life in blood. Clin Pharmacol Ther. 1972 Jul-Aug;13(4):516–519. doi: 10.1002/cpt1972134516. [DOI] [PubMed] [Google Scholar]
- Kunin C. M., Craig W. A., Kornguth M., Monson R. Influence of binding on the pharmacologic activity of antibiotics. Ann N Y Acad Sci. 1973 Nov 26;226:214–224. doi: 10.1111/j.1749-6632.1973.tb20483.x. [DOI] [PubMed] [Google Scholar]
- Merle-Melet M., Seta N., Farinotti R., Carbon C. Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits. Antimicrob Agents Chemother. 1989 Sep;33(9):1506–1510. doi: 10.1128/aac.33.9.1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rissing J. P., Buxton T. B. Effect of ibuprofen on gross pathology, bacterial count, and levels of prostaglandin E2 in experimental staphylococcal osteomyelitis. J Infect Dis. 1986 Oct;154(4):627–630. doi: 10.1093/infdis/154.4.627. [DOI] [PubMed] [Google Scholar]
- Tuomanen E., Hengstler B., Rich R., Bray M. A., Zak O., Tomasz A. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infect Dis. 1987 May;155(5):985–990. doi: 10.1093/infdis/155.5.985. [DOI] [PubMed] [Google Scholar]
- Törholm C., Hedström S. A., Herrlin K., Johnell O., Lidgren L. Chronic progressive osteoblastic osteomyelitis: a new approach to treatment. J Pediatr Orthop. 1988 May-Jun;8(3):326–332. doi: 10.1097/01241398-198805000-00014. [DOI] [PubMed] [Google Scholar]